Literature DB >> 28549100

Reply to Schuetz and Wahl.

David C Chu1, Allan J Walkey1,2.   

Abstract

Entities:  

Year:  2017        PMID： 28549100      PMCID： PMC5850534          DOI： 10.1093/cid/cix490

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   20.999


× No keyword cloud information.
  9 in total

1.  Combining ecological and individual variables to reduce confounding by indication: case study--subarachnoid hemorrhage treatment.

Authors:  S C Johnston
Journal:  J Clin Epidemiol       Date:  2000-12       Impact factor: 6.437

2.  Modeling treatment effects on binary outcomes with grouped-treatment variables and individual covariates.

Authors:  S Claiborne Johnston; Tanya Henneman; Charles E McCulloch; Mark van der Laan
Journal:  Am J Epidemiol       Date:  2002-10-15       Impact factor: 4.897

Review 3.  Procalcitonin-guided algorithms of antibiotic therapy in the intensive care unit: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Petros Kopterides; Ilias I Siempos; Iraklis Tsangaris; Argirios Tsantes; Apostolos Armaganidis
Journal:  Crit Care Med       Date:  2010-11       Impact factor: 7.598

Review 4.  A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methods.

Authors:  Til Stürmer; Manisha Joshi; Robert J Glynn; Jerry Avorn; Kenneth J Rothman; Sebastian Schneeweiss
Journal:  J Clin Epidemiol       Date:  2005-10-13       Impact factor: 6.437

5.  Procalcitonin usefulness for the initiation of antibiotic treatment in intensive care unit patients.

Authors:  Nathalie Layios; Bernard Lambermont; Jean-Luc Canivet; Philippe Morimont; Jean-Charles Preiser; Christophe Garweg; Didier Ledoux; Frédéric Frippiat; Sonia Piret; Jean-Baptiste Giot; Patricia Wiesen; Christelle Meuris; Paul Massion; Philippe Leonard; Monique Nys; Patrizio Lancellotti; Jean-Paul Chapelle; Pierre Damas
Journal:  Crit Care Med       Date:  2012-08       Impact factor: 7.598

6.  Effect of Procalcitonin Testing on Health-care Utilization and Costs in Critically Ill Patients in the United States.

Authors:  Robert A Balk; Sameer S Kadri; Zhun Cao; Scott B Robinson; Craig Lipkin; Samuel A Bozzette
Journal:  Chest       Date:  2016-08-25       Impact factor: 9.410

7.  Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial.

Authors:  Lila Bouadma; Charles-Edouard Luyt; Florence Tubach; Christophe Cracco; Antonio Alvarez; Carole Schwebel; Frédérique Schortgen; Sigismond Lasocki; Benoît Veber; Monique Dehoux; Maguy Bernard; Blandine Pasquet; Bernard Régnier; Christian Brun-Buisson; Jean Chastre; Michel Wolff
Journal:  Lancet       Date:  2010-01-25       Impact factor: 79.321

8.  Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial.

Authors:  Evelien de Jong; Jos A van Oers; Albertus Beishuizen; Piet Vos; Wytze J Vermeijden; Lenneke E Haas; Bert G Loef; Tom Dormans; Gertrude C van Melsen; Yvette C Kluiters; Hans Kemperman; Maarten J van den Elsen; Jeroen A Schouten; Jörn O Streefkerk; Hans G Krabbe; Hans Kieft; Georg H Kluge; Veerle C van Dam; Joost van Pelt; Laura Bormans; Martine Bokelman Otten; Auke C Reidinga; Henrik Endeman; Jos W Twisk; Ewoudt M W van de Garde; Anne Marie G A de Smet; Jozef Kesecioglu; Armand R Girbes; Maarten W Nijsten; Dylan W de Lange
Journal:  Lancet Infect Dis       Date:  2016-03-02       Impact factor: 25.071

9.  Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012.

Authors:  R P Dellinger; Mitchell M Levy; Andrew Rhodes; Djillali Annane; Herwig Gerlach; Steven M Opal; Jonathan E Sevransky; Charles L Sprung; Ivor S Douglas; Roman Jaeschke; Tiffany M Osborn; Mark E Nunnally; Sean R Townsend; Konrad Reinhart; Ruth M Kleinpell; Derek C Angus; Clifford S Deutschman; Flavia R Machado; Gordon D Rubenfeld; Steven Webb; Richard J Beale; Jean-Louis Vincent; Rui Moreno
Journal:  Intensive Care Med       Date:  2013-01-30       Impact factor: 17.440
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.